{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:25Z","timestamp":1789913185011,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["H2020-SC1-2016-RTD\/731944"],"award-info":[{"award-number":["H2020-SC1-2016-RTD\/731944"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["912065"],"award-info":[{"award-number":["912065"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00281","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T04:33:35Z","timestamp":1550723615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sj\u00f6gren's Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Richard","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hammenfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brith","family":"Bergum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vogelsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje M.","family":"Solberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gavasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","article-title":"The complexity of Sjogren's syndrome: novel aspects on pathogenesis","volume":"141","author":"Jonsson","year":"2011","journal-title":"Immunol Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/eos.12536","article-title":"Current concepts on Sj\u00f6gren's syndrome - classification criteria and biomarkers","volume":"126","author":"Jonsson","year":"2018","journal-title":"Eur J Oral Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1196\/annals.1384.003","article-title":"Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy","volume":"1098","author":"Fox","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in Sjogren's syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"E579","DOI":"10.1503\/cmaj.122037","article-title":"Sjogren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"Canadian Medical Association Journal"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sjogren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in Sjogren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","article-title":"An update on the role of type I interferons in systemic lupus erythematosus and Sjogren's syndrome","volume":"30","author":"Thorlacius","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/eji.201747213","article-title":"Aberrant cell signalling in PBMCs upon IFN-alpha stimulation in primary Sjogren's syndrome patients associates with type I interferon signature","volume":"48","author":"Davies","year":"2018","journal-title":"Eur J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/art.24662","article-title":"The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome","volume":"60","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nature Genetics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/1529-0131(200101)44:1<176::Aid-Anr23>3.0.Co;2-K","article-title":"Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome","volume":"44","author":"Hulkkonen","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10875-008-9212-5","article-title":"IkB alpha promoter polymorphisms in patients with primary Sjogren's syndrome","volume":"28","author":"Ou","year":"2008","journal-title":"J Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1006820","DOI":"10.1371\/journal.pgen.1006820","article-title":"Identification of a Sjogren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clim.2003.11.009","article-title":"Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications","volume":"110","author":"Krutzik","year":"2004","journal-title":"Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jim.2016.06.007","article-title":"An optimized multiplex flow cytometry protocol for the analysis of intracellular signaling in peripheral blood mononuclear cells","volume":"436","author":"Davies","year":"2016","journal-title":"J Immunol Methods"},{"key":"B18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/cyto.a.22106","article-title":"FlowRepository: a resource of annotated flow cytometry datasets associated with peer-reviewed publications","volume":"81","author":"Spidlen","year":"2012","journal-title":"Cytometry A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cyto.a.20623","article-title":"MIFlowCyt: the minimum information about a flow cytometry experiment","author":"Lee","year":"2008","journal-title":"Cytometry Part A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2006.11.007","article-title":"Expression and function of Toll-like receptors in T lymphocytes","volume":"19","author":"Kabelitz","year":"2007","journal-title":"Curr Opin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fimmu.2014.00105","article-title":"TLR\/NCR\/KIR: which one to use and when?","volume":"5","author":"Sivori","year":"2014","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-803604-4.00015-0","article-title":"Cytokines, chemokines, and the innate immune system in Sj\u00f6gren's syndrome","volume-title":"Sj\u00f6gren's Syndrome.","author":"Appel","year":"2016"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients","volume":"66","author":"van der Pouw Kraan","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15171\/apb.2015.082","article-title":"Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases","volume":"5","author":"Mohammad Hosseini","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"B30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","article-title":"Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome","volume":"76","author":"Maria","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cei.12614","article-title":"STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjogren's syndrome","volume":"181","author":"Pertovaara","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/03009740701606010","article-title":"Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren's syndrome","volume":"37","author":"Ramos","year":"2008","journal-title":"Scand J Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/sji.12368.","article-title":"TLR-7 and\u22129 stimulation of peripheral blood B cells indicate altered TLR signalling in primary Sjogren's syndrome patients by increased secretion of cytokines","volume":"82","author":"Karlsen","year":"2015","journal-title":"Scand J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.4049\/jimmunol.0803899","article-title":"Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop","volume":"183","author":"Green","year":"2009","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2016.00022","article-title":"Expression of TLR-7, MyD88, NF-kB, and INF-alpha in B lymphocytes of Mayan women with systemic lupus erythematosus in Mexico","volume":"7","author":"Pacheco","year":"2016","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjogren's Syndrome: a retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"ter Borg","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1365-3083.2001.00989.x","article-title":"Significantly depressed percentage of CD27+(memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome","volume":"54","author":"Bohnhorst","year":"2001","journal-title":"Scand J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/sji.12622","article-title":"Patients with primary Sjogren's syndrome have alterations in absolute quantities of specific peripheral leukocyte populations","volume":"86","author":"Davies","year":"2017","journal-title":"Scand J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T04:33:37Z","timestamp":1550723617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2019.00281"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00281","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"article-number":"281"}}